![Lars Guldbæk Karlsson](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Lars Guldbæk Karlsson
No open positions remaining
Profile
Dr. Lars Guldbæk Karlsson is Executive Director, Head-Research & Development at Silence Therapeutics Plc.
He is on the Board of Directors at Silence Therapeutics Plc.
Dr. Karlsson was previously employed as Senior Vice President-Global Quality by Novo Nordisk A/S and Vice President-Immunology & Fibrosis by Regulus Therapeutics, Inc.
Former positions of Lars Guldbæk Karlsson
| Companies | Position | End |
|---|---|---|
| SILENCE THERAPEUTICS PLC | Chief Tech/Sci/R&D Officer | 04/04/2016 |
| REGULUS THERAPEUTICS INC. | Corporate Officer/Principal | - |
| NOVO NORDISK A/S | Corporate Officer/Principal | - |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
5
1st degree connections
3
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 3 |
|---|---|
Novo Nordisk A/S
 Novo Nordisk A/S Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical products for diabetes care | Health Technology |
Silence Therapeutics Plc
 Silence Therapeutics Plc Miscellaneous Commercial ServicesCommercial Services Engages in the research and development of novel pharmaceutical products | Commercial Services |
Regulus Therapeutics, Inc.
 Regulus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that engages in discovering and developing of drugs | Health Technology |
- Stock Market
- Insiders
- Lars Guldbæk Karlsson
